Bronchial reactivity and fractional exhaled NO in Crohn's disease in the era of immunomodulating treatment

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 9, 2012, Pages

  Livnat, Galit ^a   Lerner, Aaron ^b   Hakim, Fahed ^a   Eshach Adiv, Orly ^a   Berkowitz, Drora ^c   Bentur, Lea ^a,d  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Airway hyperresponsiveness; Bronchial hyperreactivity; Crohn disease; Nitric oxide

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; METHACHOLINE; METHOTREXATE; NITRIC OXIDE;

ADOLESCENT; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; SYSTEMIC THERAPY;

ADOLESCENT; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROHN DISEASE; FEMALE; HUMANS; IMMUNOMODULATION; MALE; NITRIC OXIDE; SPIROMETRY; YOUNG ADULT;

EID: 84864697702     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2012.02751.x     Document Type: Article

References (30)

1. Loftus EV Jr, Sandborn WJ,. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 1-20.
2. Abraham C, Cho JH,. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-78.
3. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV,. The lung in inflammatory bowel disease. Medicine 1993; 72: 151-83.
4. Puntis JW, Tarlow MJ, Raafat F, Booth IW,. Crohn's disease of the lung. Arch Dis Child 1990; 65: 1270-1.
5. Storch I, Sachar D, Katz S,. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 104-15.
6. Basseri B, Enayati P, Marchevsky A, Papadakis KA,. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis 2010; 4: 390-7.
7. Ceyhan BB, Karakurt S, Cevik H, Sungur M,. Bronchial hyperreactivity and allergic status in inflammatory bowel disease. Respiration 2003; 70: 60-6.
8. Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A, Lazarov E, et al., The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 2000; 95: 730-4.
9. Munck A, Murciano D, Pariente R, Cezard JP, Navarro J,. Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 1995; 8: 377-80.
10. Panhuysen CI, Bleecker ER, Koeter GH, Meyers DA, Postma DS,. Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. Am J Respir Crit Care Med 1998; 157: 1734-42.
11. Koek GH, Verleden GM, Evenepoel P, Rutgeerts P,. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? Respir Med 2002; 96: 530-5.
12. Ozyilmaz E, Yildirim B, Erbas G, Akten S, Oguzulgen IK, Tunc B, et al., Value of fractional exhaled nitric oxide (FE NO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 670-6.
13. Mansi A, Cucchiara S, Greco L, Sarnelli P, Pisanti C, Franco MT, et al., Bronchial hyperresponsiveness in children and adolescents with Crohn's disease. Am J Respir Crit Care Med 2000; 161: 1051-4.
14. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al., Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-47.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al., Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. Quanjer PH, Borsboom GJ, Brunekreef B, Zach M, Forche G, Cotes JE, et al., Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995; 19: 135-42.
17. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al., Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-29.
18. ATS/ERS. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-30.
19. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K,. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002; 97: 377-81.
20. Louis E, Louis R, Shute J, Lau L, Franchimont D, Lamproye A, et al., Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999; 29: 660-6.
21. Peradzynska J, Krenke K, Lange J, Banaszkiewicz A, Lazowska-Przeorek I, Radzikowski A, et al., Low prevalence of pulmonary involvement in children with inflammatory bowel disease. Respir Med 2012; 106: 1048-54.
22. Tzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM,. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998; 157: 382-6.
23. Martin MC, Martinez A, Mendoza JL, Taxonera C, Diaz-Rubio M, Fernandez-Arquero M, et al., Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics 2007; 59: 833-7.
24. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI,. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986; 105: 883-5.
25. Nadif R, Matran R, Maccario J, Bechet M, Le Moual N, Scheinmann P, et al., Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol 2010; 104: 385-93.
26. Bernstein CN, Wajda A, Blanchard JF,. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-36.
27. D'Arienzo A, Manguso F, Scarpa R, Astarita C, D'Armiento FP, Bennato R, et al., Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link. Scand J Gastroenterol 2002; 37: 1156-63.
28. Jain N, Petruff C, Bandyopadhyay T,. Mesalamine lung toxicity. Conn Med 2010; 74: 265-7.
29. Bartholo RM, Zaltman C, Elia C, Cardoso AP, Flores V, Lago P, et al., Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease. Braz J Med Biol Res 2005; 38: 197-203.
30. Ganguli SC, Kamath MV, Redmond K, Chen Y, Irvine EJ, Collins SM, et al., A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls. Neurogastroenterol Motil 2007; 19: 961-7.